Bio

David Bell is a Director at Hampleton Partners and is based in London, UK. He has over 15 years’ experience providing investment banking advice to technology companies and entrepreneurs, including M&A, minority sale and fundraising transactions. David is also a qualified lawyer, enabling to bring to his clients a rare combination of world class legal and financial expertise. Since 2012, David has advised and invested in a range of technology and tech-enabled companies in the UK and internationally. He has advised on a broad range of established and nascent technology transactions, including enterprise and industrial software, health and medical technology, deep tech (Cyber, IoT, AI) marketing and tech enabled services. Most recently, he advised on the sale of Thoughtonomy (Intelligent Automation) to Blue Prism, and Dictate.IT (cognitive neural network powered medical speech recognition) to Clanwilliam, as well as funding rounds for two growth technology companies in financial intelligence and cloud services. David qualified as a lawyer at Linklaters where he practised for five years before his transition into investment banking. He spent his formative years in corporate finance at Goldman Sachs and Evercore Partners, before moving to advise technology companies, investors, and entrepreneurs in the mid-market. David holds an MSci and BA in Natural Sciences from the University of Cambridge, is a qualified non-practising lawyer and obtained a PGdL and LPC from Nottingham Law School. He lives in London with his better half, consultant head of neuroradiology at a leading London hospital; makes a weekly attempt to train his son's football team; is an amateur sailor; and where possible, travels extensively.